Attending 10th Annual HealthTech Investment Forum

Diaceutics PLC

07 September 2023

 

Diaceutics to attend 10^th Annual HealthTech Investment Forum in Basel on September 19

Belfast and London, 7 September 2023 - Diaceutics PLC (AIM: DXRX), a leading technology and solutions provider to the pharmaceutical industry, announces that management will attend and present at the 10^th Annual HealthTech Investment Forum in Basel, Switzerland on 19 September, 2023. Diaceutics CEO Peter Keeling will be a speaker at the Revolution in Precision Medicine Panel: Investing in Big Data & AI.

For more information, please click here.

Enquiries:

Diaceutics PLC	Tel: [phone]
Peter Keeling, Chief Executive Officer Ryan Keeling, Chief Innovation Officer Nick Roberts, Chief Financial Officer	[e-mail]
Stifel Nicolaus Europe Limited (Nomad & Broker)	Tel: [phone]
Ben Maddison
Nick Harland Kate Hanshaw
Alma PR	Tel: [phone]
Caroline Forde	[e-mail]
Matthew Young
Kinvara Verdon

About Diaceutics

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome.

We provide the world's leading pharma and biotech companies with an end-to-end commercialization solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostic Network®.

 

END